GLI1 and acute myeloid leukemia: Increased UGT1A expression in Ara-C resistant M5 AML THP-1 cells and relapsed AML after standard Ara-C therapies were observed, and elevation in GLI1 expression is sufficient to drive UGT1A dependent glucuronidation of Ara-C and drug resistance [20].